Biopharmaceutical Analysis & Statistics, October 2014 (p3)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: protein, biomedical, antibody, more »

61-100 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Sino Biopharmaceutical Limited (Symbol:1177) SWOT Analysis, Strategy, Revenues and Profits

Sino Biopharmaceutical Limited (Symbol:1177) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : China
Solco Biomedical Co., Ltd. (Symbol:043100) SWOT Analysis, Strategy, Revenues and Profits

Solco Biomedical Co., Ltd. (Symbol:043100) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : South Korea
Sun Biomedical Limited (Symbol:SBN) SWOT Analysis, Strategy, Revenues and Profits

Sun Biomedical Limited (Symbol:SBN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Australia
Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic SWOT Analysis Review

Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Intellect Neurosciences, Inc. (Intellect Neuro) is a biopharmaceutical company. The company discovers and develops therapeutic products for the treatment and prevention of Alzheimer's disease and ...

  • Industries : Biopharmaceutical
  • Countries : United States
RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary RegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is a biopharmaceutical company. The company designs, researches and develops peptides targeted at diseases with unmet medical needs. ...

  • Industries : Biopharmaceutical
  • Countries : United States, Canada
Kythera Biopharmaceuticals, Inc. (KYTH) - Financial and Strategic SWOT Analysis Review

Kythera Biopharmaceuticals, Inc. (KYTH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Kythera Biopharmaceuticals, Inc. (Kythera) is a biopharmaceutical company. The company discovers, develops and commercializes prescription products for the aesthetic medicine market. Its pipeline ...

  • Industries : Biopharmaceutical
  • Countries : United States
Synageva BioPharma Corp. (GEVA) - Financial and Strategic SWOT Analysis Review

Synageva BioPharma Corp. (GEVA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Synageva BioPharma Corp. (Synageva) is a biopharmaceutical company. The company discovers, develops and delivers medicines for patients with rare disease and unmet medical needs. Its products include ...

  • Industries : Biopharmaceutical
  • Countries : United States
STRATEC Biomedical AG (SBS) - Financial and Strategic SWOT Analysis Review

STRATEC Biomedical AG (SBS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary STRATEC Biomedical AG (STRATEC) is a medical device company. The company develops and offers automated analyzer systems, software for laboratory data management, and solutions for molecular diagnostic ...

  • Industries : Biopharmaceutical
Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Provectus Biopharmaceuticals, Inc. (Provectus) is a pharmaceutical company. The company develops and offers oncology therapies. Its products include PV-10 for melanoma, PH-10 for psoriasis, PH-10 ...

  • Industries : Biopharmaceutical
  • Countries : United States
CytoDyn Inc. (CYDY) - Financial and Strategic SWOT Analysis Review

CytoDyn Inc. (CYDY) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary CytoDyn, Inc. (CytoDyn ) is a biotechnology company. It involves in research and development of therapeutic monoclonal antibodies to treat HIV/AIDS. The company operates two subsidiaries, namely, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Affitech A/S (Symbol:AFFITECH) SWOT Analysis, Strategy, Revenues and Profits

Affitech A/S (Symbol:AFFITECH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Norway, Denmark
Amano Enzyme Inc. SWOT Analysis, Strategy, Revenues and Profits

Amano Enzyme Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Japan
Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
BC Biomedical Laboratories Ltd. SWOT Analysis, Strategy, Revenues and Profits

BC Biomedical Laboratories Ltd. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada, United Kingdom
BioMedical Technology Solutions Holdings, Inc. (Symbol:BMTL) SWOT Analysis, Strategy, Revenues and Profits

BioMedical Technology Solutions Holdings, Inc. (Symbol:BMTL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
BioTransplant Inc. SWOT Analysis, Strategy, Revenues and Profits

BioTransplant Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Huifeng BioPharmaceutical Technology Inc. (Symbol:HFGB) SWOT Analysis, Strategy, Revenues and Profits

Huifeng BioPharmaceutical Technology Inc. (Symbol:HFGB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : China
ISU ABXIS Co.,Ltd. (Symbol:086890) SWOT Analysis, Strategy, Revenues and Profits

ISU ABXIS Co.,Ltd. (Symbol:086890) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : South Korea
MP Biomedicals, LLC SWOT Analysis, Strategy, Revenues and Profits

MP Biomedicals, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Schnell Biopharmaceuticals, Inc. (Symbol:003060) SWOT Analysis, Strategy, Revenues and Profits

Schnell Biopharmaceuticals, Inc. (Symbol:003060) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : South Korea
SciGen Limited (Symbol:SIE) SWOT Analysis, Strategy, Revenues and Profits

SciGen Limited (Symbol:SIE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Singapore
Daesung Microbiological Labs, Co., Ltd. (Symbol:036480) SWOT Analysis, Strategy, Revenues and Profits

Daesung Microbiological Labs, Co., Ltd. (Symbol:036480) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical, Livestock
  • Countries : South Korea
Medy-Tox Inc. (Symbol:086900) SWOT Analysis, Strategy, Revenues and Profits

Medy-Tox Inc. (Symbol:086900) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Brazil, Thailand, South Korea, Japan, India
Sanjiu Yigong Biopharmaceutical & Chem (000403) - Financial and Strategic SWOT Analysis Review

Sanjiu Yigong Biopharmaceutical & Chem (000403) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Sanjiu Yigong Biopharmaceutical & Chemical Inc. (Sanjiu Yigong) is engaged in the development, manufacture and sale of pharmaceutical products. In adddition, the company also generates and distributes ...

  • Industries : Biopharmaceutical
  • Countries : China
Ondine Biomedical Inc. - Strategic SWOT Analysis Review

Ondine Biomedical Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Ondine Biomedical Inc. (Ondine), formerly known as Ondine Biopharma Corporation, is a biotechnology company. The company develops non-antibiotic, anti-infective therapies for bacterial, viral and ...

  • Industries : Biopharmaceutical
  • Countries : Canada
C-Pharma, Inc. (COBI) - Financial and Strategic SWOT Analysis Review

C-Pharma, Inc. (COBI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary C-Pharma, Inc. (C-Pharma), is a publicly held biotechnology company that is engaged in the development and commercialization of therapeutic and preventative products for the treatment of hepatitis ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Gene Techno Science Co., Ltd. (4584) - Financial and Strategic SWOT Analysis Review

Gene Techno Science Co., Ltd. (4584) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Gene Techno Science Co., Ltd. (GTS) is a biotechnology company. The company develops and markets drug and antibodies for intractable diseases and rare diseases. Its products include GND-001, GND-002, ...

  • Industries : Biopharmaceutical
Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins

Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins

  • $ 264
  • Industry report
  • September 2014
  • by La Merie Publishing

Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins The present Competitive Intelligence Report about prophylaxis and therapy of Rabies virus infections provides a competito ...

  • Industries : Biopharmaceutical
About 3 200 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Industry - Company Report, October 2014

  • Department of Health and Human Services
  • October 2014
    12 pages
  • Vaccine  

  • Africa  

    United States  

    Uganda  

View report >

Global Vaccine Industry

September 2014

Vaccine Market In The Us

September 2014

27 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

Merck KGaA

Germany

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.